Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: Analysis of 1365 patients in a single institution in Japan

Cancer

Volumn 100, Issue 11, 2004, Pages 2415-2421

  Toyoda, Hidenori ^a   Kumada, Takashi ^a   Kiriyama, Seiki ^a   Sone, Yasuhiro ^a   Tanikawa, Makoto ^a   Hisanaga, Yasuhiro ^a   Hayashi, Kazuhiko ^a   Honda, Takashi ^a   Kitabatake, Shusuke ^a   Kuzuya, Teiji ^a   Nonogaki, Koji ^a   Kasugai, Toshifumi ^a   Shimizu, Junichi ^a  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Child Pugh class; Hepatocellular carcinoma (HCC); Prognosis; Tumor size; Tumor stage

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; EARLY DIAGNOSIS; FEMALE; HUMAN; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 2442670625     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20289     Document Type: Article

References (26)

1. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg. 1990;211:277-287.
2. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver transplantation versus resection for hepatocellular carcinoma in cirrhosis. Ann Surg. 1993;218:145-151.
3. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699.
4. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S, Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983;148:397-401.
5. Nakamura H, Hashimoto T, Oi H, Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology. 1989;170:783-786.
6. Ebara M, Ohto M, Sugiura N, Okuda K, Kondo F, Kondo K. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: study of 95 patients. J Gastroenterol Hepatol. 1990;5:616-626.
7. Shiina S, Tagawa K, Unuma T, Terano A. Percutaneous ethanol injection therapy for treatment of hepatocellular carcinoma. AJR Am J Roentogenol. 1990;154:947-951.
8. Sato M, Watanabe Y, Ueda S, et al. Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology. 1996;110:1507-1514.
9. Livraghi T, Goldberg SN, Meloni F, Solbiati L, Gazelle GS. Hepatocellular carcinoma: comparison of efficacy between percutaneous ethanol instillation and radiofrequency. Radiology. 1999;210:655-661.
10. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232:381-391.
11. Toyoda H, Nakano S, Kumada T, et al. The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma. Oncology. 1995;52:295-299.
12. Urabe T, Kaneko S, Matsushita E, Unoura M, Kobayashi K. Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma. Oncology. 1998;55:39-47.
13. Shinagawa T, Ohto M, Kimura K, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology. 1984;86:495-502.
14. Takayasu K, Furukawa H, Wakao F, et al. CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation. AJR Am J Roentogenol. 1995;164:885-890.
15. Yamashita F, Tanaka M, Satomura S, Tanikawa K. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas. Gastroenterology. 1996;111:996-1001.
16. Nakao A, Taniguchi K, Inoue S, et al. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies. Am J Gastroenterol 1997;92:1031-1034.
17. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-649.
18. Kaplan EL, Meier P. Non parametric estimation for incomplete observation. J Am Stat Assoc. 1958;53:457-481.
19. Petro R, Pike MC. Conservation of the approximation (0-E2)/E in the log rank test for survival data on tumor incidence data. Biometrics. 1973;29:579-584.
20. Cox D. Regression models and life tables. J R Stat Soc. 1972;34:187-220.
21. El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology. 2001;33:62-65.
22. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-750.
23. Tanaka Y, Hanada K, Mizokami M, et al. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma will increase over the next two decades. Proc Natl Acad Sci USA. 2002;99:15584-15589.
24. Seno H, Ito K, Kojima K, Nakajima N, Chiba T. Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin C. J Gastroenterol Hepatol. 1999;14:811-816.
25. Sakon M, Nagano H, Dono K, et al. Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer. 2002;94:435-442.
26. Ando E, Tanaka M, Yamashita F, et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer. 2002;95:588-595.